170 related articles for article (PubMed ID: 37433436)
1. Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805.
Bottinor WJ; Flamand Y; Haas NB; ONeill AM; DiPaola RS; Subramanian P; Cella D; Hundley WG; Wagner LI; Salsman JM; Ky B
J Natl Compr Canc Netw; 2023 Jul; 21(7):725-731.e1. PubMed ID: 37433436
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.
Haas NB; Manola J; Uzzo RG; Flaherty KT; Wood CG; Kane C; Jewett M; Dutcher JP; Atkins MB; Pins M; Wilding G; Cella D; Wagner L; Matin S; Kuzel TM; Sexton WJ; Wong YN; Choueiri TK; Pili R; Puzanov I; Kohli M; Stadler W; Carducci M; Coomes R; DiPaola RS
Lancet; 2016 May; 387(10032):2008-16. PubMed ID: 26969090
[TBL] [Abstract][Full Text] [Related]
3. Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG-ACRIN E2805 trial.
Murphy CC; Fullington HM; Gerber DE; Bowman IA; Puligandla M; Dutcher JP; DiPaola RS; Haas NB
Cancer Med; 2021 Sep; 10(17):5917-5924. PubMed ID: 34405965
[TBL] [Abstract][Full Text] [Related]
4. Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial.
Lee Z; Jegede OA; Haas NB; Pins MR; Messing EM; Manola J; Wood CG; Kane CJ; Jewett MAS; Flaherty KT; Dutcher JP; DiPaola RS; Uzzo RG
J Urol; 2020 Apr; 203(4):684-689. PubMed ID: 31596672
[TBL] [Abstract][Full Text] [Related]
5. Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease.
Cioffi G; Viapiana O; Ognibeni F; Dalbeni A; Gatti D; Mazzone C; Faganello G; Di Lenarda A; Adami S; Rossini M
J Am Soc Echocardiogr; 2016 Jul; 29(7):689-98. PubMed ID: 26922258
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic Factor and Cytokine Analysis among Patients Treated with Adjuvant VEGFR TKIs in Resected Renal Cell Carcinoma.
Xu W; Puligandla M; Manola J; Bullock AJ; Tamasauskas D; McDermott DF; Atkins MB; Haas NB; Flaherty K; Uzzo RG; Dutcher JP; DiPaola RS; Bhatt RS
Clin Cancer Res; 2019 Oct; 25(20):6098-6106. PubMed ID: 31471309
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: post hoc analysis from Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) E2805.
Karam JA; Puligandla M; Flaherty KT; Uzzo RG; Matin SF; Pins MR; Wood CG; Kane C; Jewett MAS; Kim SE; Dutcher JP; DiPaola RS; Haas NB
BJU Int; 2022 Jun; 129(6):718-722. PubMed ID: 34480522
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study.
Keegan THM; Kushi LH; Li Q; Brunson A; Chawla X; Chew HK; Malogolowkin M; Wun T
J Cancer Surviv; 2018 Jun; 12(3):388-397. PubMed ID: 29427203
[TBL] [Abstract][Full Text] [Related]
9. The Promoting Resilience in Stress Management (PRISM) intervention for adolescents and young adults receiving hematopoietic cell transplantation: a randomized controlled trial protocol.
Fladeboe KM; Scott S; Comiskey L; Zhou C; Yi-Frazier JP; Rosenberg AR
BMC Palliat Care; 2022 May; 21(1):82. PubMed ID: 35585525
[TBL] [Abstract][Full Text] [Related]
10. Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events.
Son JS; Choi S; Kim K; Kim SM; Choi D; Lee G; Jeong SM; Park SY; Kim YY; Yun JM; Park SM
JAMA; 2018 Nov; 320(17):1783-1792. PubMed ID: 30398603
[TBL] [Abstract][Full Text] [Related]
11. Patterns of Relapse and Implications for Post-Nephrectomy Surveillance in Patients with High Risk Nonclear Cell Renal Cell Carcinoma: Subgroup Analysis of the Phase 3 ECOG-ACRIN E2805 Trial.
Narayan V; Puligandla M; Haas NB; Subramanian P; DiPaola RS; Uzzo R
J Urol; 2019 Jan; 201(1):62-68. PubMed ID: 30130544
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial.
Haas NB; Manola J; Dutcher JP; Flaherty KT; Uzzo RG; Atkins MB; DiPaola RS; Choueiri TK
JAMA Oncol; 2017 Sep; 3(9):1249-1252. PubMed ID: 28278333
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Prognostic Implications of Left Ventricular Systolic Dysfunction in Adults With Congenital Heart Disease.
Egbe AC; Miranda WR; Pellikka PA; DeSimone CV; Connolly HM
J Am Coll Cardiol; 2022 Apr; 79(14):1356-1365. PubMed ID: 35393016
[TBL] [Abstract][Full Text] [Related]
14. Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening.
Xanthakis V; Larson MG; Wollert KC; Aragam J; Cheng S; Ho J; Coglianese E; Levy D; Colucci WS; Michael Felker G; Benjamin EJ; Januzzi JL; Wang TJ; Vasan RS
J Am Heart Assoc; 2013 Nov; 2(6):e000399. PubMed ID: 24200688
[TBL] [Abstract][Full Text] [Related]
15. Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805.
Jilaveanu LB; Puligandla M; Weiss SA; Wang XV; Zito C; Flaherty KT; Boeke M; Neumeister V; Camp RL; Adeniran A; Pins M; Manola J; DiPaola RS; Haas NB; Kluger HM
Clin Cancer Res; 2018 Jan; 24(1):217-223. PubMed ID: 29066509
[No Abstract] [Full Text] [Related]
16. Trends in Cancer Incidence in US Adolescents and Young Adults, 1973-2015.
Scott AR; Stoltzfus KC; Tchelebi LT; Trifiletti DM; Lehrer EJ; Rao P; Bleyer A; Zaorsky NG
JAMA Netw Open; 2020 Dec; 3(12):e2027738. PubMed ID: 33258907
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Disease Risk Profiles in Survivors of Adolescent and Young Adult (AYA) Cancer: The Kaiser Permanente AYA Cancer Survivors Study.
Chao C; Xu L; Bhatia S; Cooper R; Brar S; Wong FL; Armenian SH
J Clin Oncol; 2016 May; 34(14):1626-33. PubMed ID: 26951318
[TBL] [Abstract][Full Text] [Related]
18. Fatigue among patients with renal cell carcinoma receiving adjuvant sunitinib or sorafenib: patient-reported outcomes of ECOG-ACRIN E2805 trial.
Zhao F; Cella D; Manola J; DiPaola RS; Wagner LI; Haas NSB
Support Care Cancer; 2018 Jun; 26(6):1889-1895. PubMed ID: 29274030
[TBL] [Abstract][Full Text] [Related]
19. The impact of diabetes on the prognostic value of left ventricular function following percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society.
Jackson M; Austin D; Kwok CS; Rashid M; Kontopantelis E; Ludman P; de Belder M; Mamas MA; Zaman A
Catheter Cardiovasc Interv; 2018 Nov; 92(6):E393-E402. PubMed ID: 29726633
[TBL] [Abstract][Full Text] [Related]
20. Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life.
Yano Y; Reis JP; Colangelo LA; Shimbo D; Viera AJ; Allen NB; Gidding SS; Bress AP; Greenland P; Muntner P; Lloyd-Jones DM
JAMA; 2018 Nov; 320(17):1774-1782. PubMed ID: 30398601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]